[Long-term treatment with oral ketamine. Case report of a female patient with therapy-resistant post-herpetic neuralgia].
Postherpetic neuralgia can lead to therapy-resistant neuropathic pain. We report the case of a 74-year-old woman with postherpetic perineal neuralgia resistant to opioids and antiepileptic drugs who has been successfully treated with oral ketamine for 28 months. Pain scores were reduced by more than 50%, despite dose reduction of other analgetic drugs. Significant side effects have not yet been reported. Despite "off-label" use, ketamine is an important third line option in cases of therapy-resistant neuropathic pain.
Zimmer
C
C
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Marienhospital Bottrop gGmbH, Josef-Albers-Str. 70, 46236 Bottrop. christian.zimmer@mhb-bottrop.de
Treschan
T A
TA
Meier
S
S
Nosch
M
M
D000284:Administration, Oral; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage*; D008134:Long-Term Care; D051474:Neuralgia, Postherpetic / Q000188:drug therapy*; D010147:Pain Measurement; D010148:Intractable Pain / Q000188:drug therapy
D000700:Analgesics; D007649:Ketamine
Br J Anaesth. 1981 Aug;53(8):805-10
7272143
Pain. 1999 Nov;83(2):283-7
10534600
Pain. 1995 May;61(2):221-228
7659432
Pain Med. 2008 Mar;9(2):253-7
18298710
Anesth Analg. 2003 Dec;97(6):1730-1739
14633551
Neurobiol Dis. 1998 Oct;5(4):209-27
9848092
J Pain Symptom Manage. 1999 Jul;18(1):61-6
10439575
PLoS Med. 2005 Jul;2(7):e164
16013891
Pain. 1991 Mar;44(3):293-299
1828878
Clin J Pain. 1994 Sep;10(3):240-2
7833583